Cited by

• New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer.

  Connors SK, Chornokur G, Kumar NB. Connors SK, et al. Nutr Cancer. 2012;64(1):4-22. doi: 10.1080/01635581.2012.630158. Epub 2011 Nov 18. Nutr Cancer. 2012. PMID: 22098273 Free PMC article. Review.
• Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: inhibition of metastatic tumor growth in severe combined immunodeficiency mice.

  Stearns ME, Amatangelo MD, Varma D, Sell C, Goodyear SM. Stearns ME, et al. Am J Pathol. 2010 Dec;177(6):3169-79. doi: 10.2353/ajpath.2010.100330. Epub 2010 Oct 22. Am J Pathol. 2010. PMID: 20971741 Free PMC article.
• Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.

  Kumar N, Chornokur G. Kumar N, et al. Transl Med (Sunnyvale). 2012 Dec 31;Suppl 2:005. doi: 10.4172/2161-1025.S2-005. Transl Med (Sunnyvale). 2012. PMID: 24527269 Free PMC article.
• Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention.

  Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty J, Williams CR, Schreiber F, Parnes HL, Sebti S, Kazi A, Kang L, Quinn G, Smith T, Yue B, Diaz K, Chornokur G, Crocker T, Schell MJ. Kumar NB, et al. Cancer Prev Res (Phila). 2015 Oct;8(10):879-87. doi: 10.1158/1940-6207.CAPR-14-0324. Epub 2015 Apr 14. Cancer Prev Res (Phila). 2015. PMID: 25873370 Free PMC article. Clinical Trial.
• Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins.

  Kumar NB, Pow-Sang J, Spiess PE, Park J, Salup R, Williams CR, Parnes H, Schell MJ. Kumar NB, et al. Oncotarget. 2016 Oct 25;7(43):70794-70802. doi: 10.18632/oncotarget.12222. Oncotarget. 2016. PMID: 28053292 Free PMC article. Clinical Trial.